In prostate cancer radiotherapy, it is important to accurately identify and protect healthy organs near the prostate. One of these structures is the urethra, the tube that carries urine from the bladder out of the body. If the urethra receives too much radiation, patients may experience urinary side effects. Current CT scans used for treatment planning do not clearly show the urethra unless a urinary catheter is inserted. While a catheter can improve visibility, it may cause discomfort, increase the risk of infection, and slightly change the natural position of the urethra. MRI scans can also help visualize the urethra, but they are not always available and may not fit easily into all treatment workflows. Photon-counting CT (PCCT) is a new type of CT scanner that produces higher-quality images with better detail. This technology may allow doctors to see the urethra without using a catheter. The purpose of this pilot study is to investigate whether PCCT can reliably visualize the urethra in prostate cancer patients without the need for catheter insertion. If successful, this approach could make treatment planning more comfortable and less invasive while helping doctors better protect healthy tissues during radiotherapy.
Study Type
OBSERVATIONAL
Enrollment
20
Two sets of images will be acquired on TC photon counting: the first without a catheter, and the second after catheter placement by healthcare personnel. Comparison between images with and without catheter
IRCCS Humanitas Research Hospital
Rozzano, Milan, Italy
RECRUITINGquality of imaging
Quantitative quality of prostatic urethra contouring on non-catheter photon-counting CT, assessed using spatial overlap and boundary agreement metrics, specifically the Dice similarity coefficient (DSC) and the 95th percentile Hausdorff distance (HD95), with corresponding confidence intervals.
Time frame: Day of TC acquisition
evaluate inter-observer agreement of urethral contours generated on non-catheter PCCT
Inter-observer agreement assessed using spatial overlap and distance-based metrics (DSC and HD95).
Time frame: immediately after TC acquisition
compare non-catheter urethral contours with catheter-based reference contours
Agreement between non-catheter and catheter-based contours using spatial and geometric metrics (DSC and HD95).
Time frame: immediately after TC acquisition
assess contouring confidence and contouring time across different PCCT reconstruction approaches
Contour confidence score and contour time compared to standardized clinical times
Time frame: immediately after TC acquisition
explore segmental urethral visualization along its anatomical course.
evaluating segment-specific visualization quality through image quality parameters and artifacts affecting visualization
Time frame: immediately after TC acquisition
Quantitative contour-derived parameters
explore quantitative imaging and contour-derived parameters related to urethral conspicuity and reproducibility
Time frame: immediately after TC acquisition
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.